Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1673305 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Myocyte Enhancer Factor 2A (MEF2A) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to a sequence at the C-terminal of human MEF2A, different from the related mouse and rat sequences by one amino acid.Immunogen affinity purified.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- C-Term
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time.
- Handling
- Avoid repeated freezing and thawing.
Submitted references The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction.
Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number.
Transcription factor MEF2A mutations in patients with coronary artery disease.
González P, García-Castro M, Reguero JR, Batalla A, Ordóñez AG, Palop RL, Lozano I, Montes M, Alvarez V, Coto E
Journal of medical genetics 2006 Feb;43(2):167-9
Journal of medical genetics 2006 Feb;43(2):167-9
Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number.
Flavell SW, Cowan CW, Kim TK, Greer PL, Lin Y, Paradis S, Griffith EC, Hu LS, Chen C, Greenberg ME
Science (New York, N.Y.) 2006 Feb 17;311(5763):1008-12
Science (New York, N.Y.) 2006 Feb 17;311(5763):1008-12
Transcription factor MEF2A mutations in patients with coronary artery disease.
Bhagavatula MR, Fan C, Shen GQ, Cassano J, Plow EF, Topol EJ, Wang Q
Human molecular genetics 2004 Dec 15;13(24):3181-8
Human molecular genetics 2004 Dec 15;13(24):3181-8
No comments: Submit comment
No validations: Submit validation data